We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
New researchThe sub-₹100 crore acquisition market, sized.Read the research →
Home/ Cases/ Pharmaceuticals/ Leesa Lifesciences Private Limited
✓ Resolved — plan approved

Leesa Lifesciences Private Limited

Corporate insolvency resolution — resolution plan approved · source: NCLT order, 18 Oct 2022

Sector Pharmaceuticals Bench NCLT Hyderabad Last process activity 2.7 years ago · tribunal order
Acquired by
PSN Medicare Private Limited
Named in the NCLT plan-approval order.

Case record

at a glance

Admitted by the Hyderabad bench on a petition by a financial creditor. Current status: Resolved.

Admission to plan approval
2 yr 8 mo
This case
NCLT Hyderabad median · 1 yr 4 mo
All India median · 1 yr 8 mo
Medians: time from admission to plan approval, over closed cases (n = 125 / 1,536). Pre-packs left out.
The company
Private limited company in Pharmaceuticals, registered in Telangana
Admitted claims
₹10–100 Cr
Where the process stands
Admitted→Expression of Interest invited→Resolution plan approved
How cases like this ended
Pharmaceuticals · 42 closed
Resolved 55% · Liquidation 33% · Withdrawn or closed 12%
NCLT Hyderabad · 483 closed
Resolved 26% · Liquidation 45% · Withdrawn or closed 29%
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

9 sections of this case are locked.

Admitted claims & creditor classesRecovery, haircut & plan valueCommittee of creditorsFinancialsCompany & MCA recordTimeline & key dates · 4 tribunal ordersProfessionalsBenchmarks against this caseIntelligence note
See plans →
Sources, basis and disclaimers → ·
report an error